Fenofibrate

AKT serine/threonine kinase 1 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33772142 PPARα agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARα/AMPK/AKT/FoxO1 pathway. 2022 Jan 2
2 30774365 Fenofibrate potentiates chemosensitivity to human breast cancer cells by modulating apoptosis via AKT/NF-κB pathway. 2019 4
3 29305864 Fenofibrate inhibits mTOR-p70S6K signaling and simultaneously induces cell death in human prostate cancer cells. 2018 Jan 29 1
4 27313493 Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer. 2016 1
5 26387199 [The effect of relgulation of PPAR-α on cardiac hypertrophy and the relationship between the effect of PPAR-α with PI3K/Akt/mTOR pathway]. 2015 May 1
6 23399562 Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP. 2013 Mar 8 1
7 20580385 Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation. 2011 Apr 1
8 21514001 Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms. 2011 Aug 3
9 18346759 PPARalpha activators upregulate eNOS activity and inhibit cytokine-induced NF-kappaB activation through AMP-activated protein kinase activation. 2008 Apr 9 1
10 18546270 Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. 2008 Sep 1 1
11 17597616 Activation of peroxisome proliferator-activated receptor-alpha prevents glycogen synthase 3beta phosphorylation and inhibits cardiac hypertrophy. 2007 Jul 10 1
12 15843896 Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt. 2005 Mar 5
13 12785728 Fenofibrate inhibits angiogenesis in vitro and in vivo. 2003 Apr 1